Efficacy of immune-checkpoint inhibitors in advanced non-small cell lung cancer patients with different metastases

BACKGROUND: To investigate the significance of metastatic sites and their numbers to the efficacy of immune checkpoint inhibitors (ICIs) in patients with advanced non-small cell lung cancer (NSCLC). METHODS: A total of 232 patients who received ICI monotherapy or ICI-based combination therapy were r...

Descripción completa

Detalles Bibliográficos
Autores principales: Qiao, Meng, Zhou, Fei, Hou, Likun, Li, Xuefei, Zhao, Chao, Jiang, Tao, Gao, Guanghui, Su, Chunxia, Wu, Chunyan, Ren, Shengxiang, Zhou, Caicun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7859789/
https://www.ncbi.nlm.nih.gov/pubmed/33553327
http://dx.doi.org/10.21037/atm-20-1471

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7859789/
https://www.ncbi.nlm.nih.gov/pubmed/33553327
http://dx.doi.org/10.21037/atm-20-1471

Ejemplares similares